A research update on the anticancer effects of bufalin and its derivatives.

Lan, Yu-Long; Lou, Jia-Cheng; Jiang, Xue-Wen; Wang, Xun; Xing, Jin-Shan; Li, Shao; Zhang, Bo

Lan, Yu-Long; Lou, Jia-Cheng; Jiang, Xue-Wen; Wang, Xun; Xing, Jin-Shan; Li, Shao; Zhang, Bo.

Afiliação

Lan YL; Department of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Lou JC; Department of Neurosurgery, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, P.R. China.
Jiang XW; Liaoning Provincial Key Laboratory of Cerebral Diseases, Department of Physiology, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Wang X; Department of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Xing JS; Department of Neurosurgery, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, P.R. China.
Li S; Department of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Zhang B; Department of Neurosurgery, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, P.R. China.

Oncol Lett ; 17(4): 3635-3640, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30915168

Palavras-chave

Chansu; bufalin; cancer; mechanism; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Oncol Lett Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google